14.3 Clinical Studies in Adults with Type 2 Diabetes In a randomized, controlled clinical study (Study E) in 570 adults with type 2 diabetes, insulin glargine was evaluated for 52 weeks in combination with oral anti-diabetic medications (a sulfonylurea, metformin, acarbose, or combinations of these drugs)
Many patients on GLP-1 medications lose an average of 10% to 15% of their body weight over 12-18 months, depending on their body mass index, dose, and adherence to a treatment plan
Wang, Y., Viscarra, J., Kim, S
Quick Answer: GLP-1 injections can cause tiredness, classified as a common side effect affecting between 1 in 10 and 1 in 100 people, particularly at higher doses used for weight management
Let us help guide you through every stepfrom initial assessment to ongoing support
The official antioxidants definition is any substance that inhibits oxidation, which helps prevent free radical formation and protect against disease